PMC:7029759 / 33051-33263 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"860","span":{"begin":41,"end":45},"obj":"Gene"},{"id":"861","span":{"begin":107,"end":111},"obj":"Gene"},{"id":"876","span":{"begin":58,"end":69},"obj":"Disease"}],"attributes":[{"id":"A860","pred":"tao:has_database_id","subj":"860","obj":"Gene:59272"},{"id":"A861","pred":"tao:has_database_id","subj":"861","obj":"Gene:59272"},{"id":"A876","pred":"tao:has_database_id","subj":"876","obj":"MESH:D055370"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"from the recombinant protein delivery of ACE2 in treating lung injury, so it is recommended that retaining ACE2 enzyme activity be pursued first. Another potential concern is that receptor binding via an antibody"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T413","span":{"begin":41,"end":45},"obj":"G_3;PG_10;PR:000003622"},{"id":"T412","span":{"begin":58,"end":62},"obj":"UBERON:0002048"},{"id":"T411","span":{"begin":107,"end":111},"obj":"G_3;PG_10;PR:000003622"},{"id":"T410","span":{"begin":204,"end":212},"obj":"GO:0042571"}],"text":"from the recombinant protein delivery of ACE2 in treating lung injury, so it is recommended that retaining ACE2 enzyme activity be pursued first. Another potential concern is that receptor binding via an antibody"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T214","span":{"begin":21,"end":28},"obj":"Body_part"},{"id":"T215","span":{"begin":58,"end":62},"obj":"Body_part"},{"id":"T216","span":{"begin":204,"end":212},"obj":"Body_part"}],"attributes":[{"id":"A214","pred":"fma_id","subj":"T214","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A215","pred":"fma_id","subj":"T215","obj":"http://purl.org/sig/ont/fma/fma7195"},{"id":"A216","pred":"fma_id","subj":"T216","obj":"http://purl.org/sig/ont/fma/fma62871"}],"text":"from the recombinant protein delivery of ACE2 in treating lung injury, so it is recommended that retaining ACE2 enzyme activity be pursued first. Another potential concern is that receptor binding via an antibody"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T21","span":{"begin":58,"end":62},"obj":"Body_part"}],"attributes":[{"id":"A21","pred":"uberon_id","subj":"T21","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"}],"text":"from the recombinant protein delivery of ACE2 in treating lung injury, so it is recommended that retaining ACE2 enzyme activity be pursued first. Another potential concern is that receptor binding via an antibody"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T119","span":{"begin":63,"end":69},"obj":"Disease"}],"attributes":[{"id":"A119","pred":"mondo_id","subj":"T119","obj":"http://purl.obolibrary.org/obo/MONDO_0021178"}],"text":"from the recombinant protein delivery of ACE2 in treating lung injury, so it is recommended that retaining ACE2 enzyme activity be pursued first. Another potential concern is that receptor binding via an antibody"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T340","span":{"begin":58,"end":62},"obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"T341","span":{"begin":58,"end":62},"obj":"http://www.ebi.ac.uk/efo/EFO_0000934"},{"id":"T342","span":{"begin":119,"end":127},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"}],"text":"from the recombinant protein delivery of ACE2 in treating lung injury, so it is recommended that retaining ACE2 enzyme activity be pursued first. Another potential concern is that receptor binding via an antibody"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T151","span":{"begin":21,"end":28},"obj":"Chemical"}],"attributes":[{"id":"A151","pred":"chebi_id","subj":"T151","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"from the recombinant protein delivery of ACE2 in treating lung injury, so it is recommended that retaining ACE2 enzyme activity be pursued first. Another potential concern is that receptor binding via an antibody"}